Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Tuberculosis (TB), caused by M. tuberculosis (Mtb), remains a leading cause of morbidity and mortality worldwide, despite widespread use of the only licensed vaccine, Bacille Calmette Guerin (BCG). Eradication of tuberculosis will require a more effective vaccine, yet evaluation of new vaccine candidates is hampered by lack of defined correlates of protection. Animal and human studies of intracellular pathogens have extensively evaluated polyfunctional CD4+ T cells producing multiple proinflammatory cytokines (IFN-, TNF-, IL-2) as a possible correlate of protection from infection and disease. Herein, we review the published literature that evaluates whether or not BCG and/or novel TB vaccine candidates induce polyfunctional CD4+ T cells and if these T cell responses confer correlate with vaccine-mediated protection. Ample evidence suggests that BCG and several novel vaccine candidates evaluated in animal models and humans induce polyfunctional CD4+ T cells. However, while a number of studies utilizing the mouse TB model support that polyfunctional CD4+ T cells are associated with vaccine-induced protection, other studies in mouse and human infants demonstrate no correlation between these T cell responses and protection. We conclude that induction of polyfunctional CD4+ T cells is certainly not sufficient and may not even be necessary to mediate protection and suggest that other functional attributes, such as additional effector functions, T cell differentiation state, tissue homing potential or long-term survival capacity of the T cell may be equally or even more important to promote protection. Thus, a correlate of protection for TB vaccine development remains elusive. Future studies should address polyfunctional CD4+ T cells within the context of more comprehensive immunological signatures of protection that include other functions and phenotypes of T cells as well as the full spectrum of immune cells and mediators that participate in the immune response against Mtb.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liew, F. Y., Li, Y., & Millott, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4306 · Cited by 522 · cited 1×
“major infection (19, 20), which in turn is associated with enhanced control of disease by the combination of IFN-γ and TNF-α in the murine model (20).”
BackgroundBogdan, C., Moll, H., Solbach, W., & Röllinghoff, M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200528 · Cited by 183
Ballester, M., Nembrini, C., Dhar, N., de Titta, A., de Piano, C., Pasquier, M., Simeoni, E., van der Vlies, A. J., McKinney, J. D., Hubbell, J. A., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.039 · Cited by 130 · cited 2×
“induced more polyfunctional Ag85B-specific CD4+ T cells in spleen pre-challenge than did Ag85B:CpG without NP and this correlated with better protection in the lung (50).”
Background
Cited by
Prevention of tuberculosis in macaques after intravenous BCG immunization
Darrah, P. A., Zeppa, J. J., Maiello, P., Hackney, J. A., Wadsworth, M. H., Hughes, T. K., Pokkali, S., Swanson, P. A., Grant, N. L., Rodgers, M. A., et al. (2020) · Nature · doi:10.1038/s41586-019-1817-8 · Cited by 586
The status of tuberculosis vaccine development
Schrager, L. K., Vekemens, J., Drager, N., Lewinsohn, D. M., & Olesen, O. F. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30625-5 · Cited by 196
Self-citationAn RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis
Larsen, S. E., Erasmus, J. H., Reese, V. A., Pecor, T., Archer, J., Kandahar, A., Hsu, F.-C., Nicholes, K., Reed, S. G., Baldwin, S. L., et al. (2023) · Vaccines · doi:10.3390/vaccines11010130 · Cited by 66
Metadata
- Authors
- Lewinsohn, D. A., Lewinsohn, D. M., & Scriba, T. J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-10-05
- Volume
- 8
- Pages
- 1262-1262
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2762649195
- Cited by
- 180
- References
- 3
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination. https://app.cochat.ai/papers/10.3389/fimmu.2017.01262
- The paper
- Lewinsohn, D. A., Lewinsohn, D. M., & Scriba, T. J. (2017). Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.01262
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.